• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Real-world data on pain management and effectiveness of anti-tumour necrosis factor agents in refractory livedoid vasculopathy.

作者信息

Gao Y, Jin H

机构信息

Department of Dermatology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China.

出版信息

J Eur Acad Dermatol Venereol. 2022 Jan;36(1):e46-e48. doi: 10.1111/jdv.17613. Epub 2021 Sep 19.

DOI:10.1111/jdv.17613
PMID:34416092
Abstract
摘要

相似文献

1
Real-world data on pain management and effectiveness of anti-tumour necrosis factor agents in refractory livedoid vasculopathy.关于难治性类脂质渐进性坏死性血管病中疼痛管理及抗肿瘤坏死因子药物疗效的真实世界数据。
J Eur Acad Dermatol Venereol. 2022 Jan;36(1):e46-e48. doi: 10.1111/jdv.17613. Epub 2021 Sep 19.
2
Rapid remission of severe pain from livedoid vasculopathy by apixaban.阿哌沙班使类脂质渐进性坏死性血管病所致的剧痛迅速缓解。
J Eur Acad Dermatol Venereol. 2017 Jan;31(1):e45-e46. doi: 10.1111/jdv.13691. Epub 2016 May 11.
3
Excellent Long-term Clinical Response to Rivaroxaban in Livedoid Vasculopathy: A Retrospective Study.利伐沙班治疗萎缩性血管病的长期临床疗效卓越：一项回顾性研究
Actas Dermosifiliogr. 2023 Feb;114(2):183-185. doi: 10.1016/j.ad.2022.03.022. Epub 2022 Sep 14.
4
Efficacy of intravenous immunoglobulins in livedoid vasculopathy: long-term follow-up of 11 patients.静脉注射免疫球蛋白治疗类脂质渐进性坏死性血管炎的疗效：11 例患者的长期随访。
J Am Acad Dermatol. 2014 Oct;71(4):738-44. doi: 10.1016/j.jaad.2014.05.039. Epub 2014 Jul 9.
5
A novel combination ("CHAP") regimen for management of livedoid vasculopathy in 12 patients.
J Am Acad Dermatol. 2023 Mar;88(3):672-674. doi: 10.1016/j.jaad.2022.06.1188. Epub 2022 Jul 1.
6
The potential role of tumor necrosis factor-α in thrombosis in livedoid vasculopathy.肿瘤坏死因子-α在类脂质渐进性坏死症血栓形成中的潜在作用。
Arch Dermatol Res. 2024 Apr 18;316(5):124. doi: 10.1007/s00403-024-02857-w.
7
Evaluating complement dysregulation in livedoid vasculopathy using a functional assay.使用功能测定法评估类脂质渐进性坏死症中的补体失调。
Blood Adv. 2023 Nov 14;7(21):6604-6607. doi: 10.1182/bloodadvances.2022009142.
8
Efficacy of adalimumab in the treatment of refractory livedoid vasculopathy: Case report and literature review.阿达木单抗治疗难治性类脂质渐进性坏死性血管病的疗效：病例报告及文献综述
Dermatol Ther. 2022 Sep;35(9):e15666. doi: 10.1111/dth.15666. Epub 2022 Jul 9.
9
Refractory livedoid vasculopathy in a child successfully treated with baricitinib.儿童难治性类脂质渐进性坏死性血管病经巴瑞替尼治疗成功
Dermatol Ther. 2022 Aug;35(8):e15659. doi: 10.1111/dth.15659. Epub 2022 Jul 4.
10
Exacerbation of livedoid vasculopathy after coronavirus disease 2019.2019冠状病毒病后类脂质渐进性坏死性血管病加重
Eur J Dermatol. 2022 Jan 1;32(1):129-131. doi: 10.1684/ejd.2022.4200.

引用本文的文献

1
Anti-Interleukin 17A Biologic Therapy Attempts on Livedoid Vasculopathy: A Report of Case Series.抗白细胞介素17A生物疗法治疗类脂质渐进性坏死性血管病：病例系列报告
Clin Cosmet Investig Dermatol. 2024 May 9;17:1043-1048. doi: 10.2147/CCID.S455903. eCollection 2024.
2
Pain Management Options in a Patient with Livedoid Vasculopathy and Peripheral Neuropathy.萎缩性紫癜性血管病合并周围神经病变患者的疼痛管理方案
Eur J Case Rep Intern Med. 2023 Jan 30;10(1):003727. doi: 10.12890/2023_003727. eCollection 2023.
3
Livedoid vasculopathy - A diagnostic and therapeutic challenge.
萎缩性硬化性苔藓样血管病——诊断与治疗的挑战。
Front Med (Lausanne). 2022 Oct 3;9:1012178. doi: 10.3389/fmed.2022.1012178. eCollection 2022.